PMID: 2158274DOI: 10.1128/aac.34.1.8Jan 1, 1990Paper

Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems.

Antimicrobial Agents and Chemotherapy
T D GootzJ A Sutcliffe
Get PDF

Abstract

No abstract listed.

References

Point mutations at the thymidine kinase locus in L5178Y mouse lymphoma cells. I. Application to genetic toxicological testing

Dec 1, 1979·Mutation Research·D E AmacherV A Ray

Laboratory procedure for assessing specific locus mutations at the TK locus in cultured L5178Y mouse lymphoma cells

Feb 1, 1975·Mutation Research·D Clive, J F Spector

In vitro assays used to measure the activity of topoisomerases.

Jan 1, 1990·Antimicrobial Agents and Chemotherapy·J F BarrettT D Gootz

Characterization of DNA primase separated from DNA polymerase alpha-DNA primase complex of calf thymus

Jun 1, 1986·Journal of Biochemistry·R SuzukiS Yoshida

Genetic profile of a nalidixic acid analog: a model for the mechanism of sister chromatid exchange induction

Jan 1, 1989·Environmental and Molecular Mutagenesis·H E HoldenM G Wahrenburg

Biochemical characteristics and physiological significance of major DNA topoisomerases.

Dec 1, 1989·Antimicrobial Agents and Chemotherapy·J A SutcliffeJ F Barrett

The mouse bone marrow micronucleus assay can be used to distinguish aneugens from clastogens.

Jan 1, 1989·Mutagenesis·K VanderkerkenM Kirsch-Volders

Structure-activity relationships of the fluoroquinolones.

Feb 1, 1989·Antimicrobial Agents and Chemotherapy·D T Chu, P B Fernandes

Computer automated structure evaluation of quinolone antibacterial agents.

Nov 1, 1987·Antimicrobial Agents and Chemotherapy·G KlopmanH S Rosenkranz

Effect of DNA gyrase inhibitors pefloxacin, five other quinolones, novobiocin, and clorobiocin on Escherichia coli topoisomerase I.

Dec 1, 1987·Antimicrobial Agents and Chemotherapy·X TabaryF Le Goffic

Effects of fleroxacin on HeLa cell functions and topoisomerase II

Oct 1, 1988·The Journal of Antimicrobial Chemotherapy·Y OomoriT Yokota

4-Quinolone antibiotics: positive genotoxic screening tests despite an apparent lack of mutation induction

Mar 1, 1989·Mutation Research·A BredbergA Forsgren

Effect of 4-quinolones and novobiocin on calf thymus DNA polymerase alpha primase complex, topoisomerases I and II, and growth of mammalian lymphoblasts.

Jun 1, 1986·Antimicrobial Agents and Chemotherapy·P HussyU Schomburg

Short-term tests and the myth of the non-clastogenic mutagen

Sep 1, 1988·Mutagenesis·M H Green

Evaluation of the DNA-damaging and mutagenic activity of oxolinic and pipemidic acids by the granuloma pouch assay

Sep 1, 1988·Mutagenesis·A Maura, A Pino

Genotoxic and epigenetic chemical carcinogenesis: one process, different mechanisms

Sep 1, 1988·Trends in Pharmacological Sciences·W K Lutz, P Maier

Cost-effectiveness of short-term tests for carcinogenicity

Nov 6, 1986·Nature·L B Lave, G S Omenn

No cytogenetic effects of quinolone treatment in humans.

Jun 1, 1988·Antimicrobial Agents and Chemotherapy·F MitelmanJ Wadstein

Specific toxicologic aspects of the quinolones

Jan 1, 1988·Reviews of Infectious Diseases·W ChristB Ulbrich

7-substituted 5-amino-1-cyclopropyl-6,8-difluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylic acids: synthesis and biological activity of a new class of quinolone antibacterials.

Mar 1, 1988·Journal of Medicinal Chemistry·J M DomagalaA K Trehan

Do short-term tests predict rodent carcinogenicity?

Sep 2, 1988·Science·S S Young

Problems and pitfalls in assessing human T-lymphocyte mutant frequencies

Aug 1, 1987·Mutation Research·T FeatherstoneH J Evans

Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics

Apr 1, 1986·Journal of Clinical and Hospital Pharmacy·D B Jack

Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays

May 22, 1987·Science·R W TennantB Anderson

4-Quinolone drugs affect cell cycle progression and function of human lymphocytes in vitro.

May 1, 1987·Antimicrobial Agents and Chemotherapy·A ForsgrenT F Tedder

Effects of ciprofloxacin on eucaryotic pyrimidine nucleotide biosynthesis and cell growth.

May 1, 1987·Antimicrobial Agents and Chemotherapy·A ForsgrenT F Tedder

A guide for the performance of the Chinese hamster ovary cell/hypoxanthine-guanine phosphoribosyl transferase gene mutation assay.

Oct 1, 1987·Mutation Research·A P LiL L Yang

Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cells

Mar 1, 1987·Mutation Research·D M DeMariniM M Moore

Use of cultured human tissues and cells in carcinogenesis research

Jan 1, 1985·Journal of Cancer Research and Clinical Oncology·E W Gabrielson, C C Harris

ATP-dependent DNA topoisonmerase from D. melanogaster reversibly catenates duplex DNA rings

Aug 1, 1980·Cell·T Hsieh, D Brutlag

DNA topoisomerases from rat liver: physiological variations

Feb 25, 1983·Nucleic Acids Research·M DuguetA M De Recondo

The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria

Sep 9, 1983·Biochimica Et Biophysica Acta·F J CastoraM V Simpson

Revised methods for the Salmonella mutagenicity test

May 1, 1983·Mutation Research·D M Maron, B N Ames

Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase

Jun 29, 1984·Biochemical and Biophysical Research Communications·R RusquetJ C David

Nalidixic acid, oxolinic acid, and novobiocin inhibit yeast glycyl- and leucyl-transfer RNA synthetases

Jul 24, 1981·Science·H T WrightD J Goldstein

Detection of unscheduled DNA synthesis in hepatocytes isolated from rats treated with genotoxic agents: an in vivo- in vitro assay for potential carcinogens and mutagens

Jul 1, 1980·Carcinogenesis·J C Mirsalis, B E Butterworth

❮ Previous
Next ❯

Citations

Using yeast to study resistance to topoisomerase II-targeting drugs

Jan 1, 1994·Cancer Chemotherapy and Pharmacology·J L Nitiss

Immunological aspects of new quinolones

Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I Shalit

Quinolone effects in the SOS chromotest and the synthesis of biomacromolecules

Jan 1, 1996·Folia Microbiologica·L Majtánová, V Majtán

Ciprofloxacin-induced antibacterial activity is reversed by vitamin E and vitamin C.

Feb 22, 2012·Current Microbiology·Majed M MasadehAshraf I Shaweesh

Topoisomerase inhibition, nucleolytic and electrolytic contribution on DNA binding activity exerted by biological active analogue of coordination compounds

Mar 7, 2012·Applied Biochemistry and Biotechnology·Mohan N PatelPromise A Dosi

Structure-activity relationships in DNA gyrase inhibitors

Jan 1, 1990·Pharmacology & Therapeutics·S Rádl

Antimycobacterial quinolones: a comparative analysis of structure-activity and structure-cytotoxicity relationships

Jan 1, 1996·Research in Microbiology·G KlopmanM R Jacobs

Antimutagens reduce ofloxacin-induced bleaching in Euglena gracilis

Feb 29, 1996·Mutation Research·L EbringerN Lahitová

Arabidopsis thaliana DNA gyrase is targeted to chloroplasts and mitochondria.

May 12, 2004·Proceedings of the National Academy of Sciences of the United States of America·Melisa K WallAnthony Maxwell

Bactericidal antibiotics induce mitochondrial dysfunction and oxidative damage in Mammalian cells

Jul 5, 2013·Science Translational Medicine·Sameer KalghatgiJames J Collins

In vitro assays used to measure the activity of topoisomerases.

Jan 1, 1990·Antimicrobial Agents and Chemotherapy·J F BarrettT D Gootz

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

Oct 1, 1990·Antimicrobial Agents and Chemotherapy·N J MoreauX Tabary

Induction of calf thymus topoisomerase II-mediated DNA breakage by the antibacterial isothiazoloquinolones A-65281 and A-65282.

Jan 1, 1992·Antimicrobial Agents and Chemotherapy·W E KohlbrennerD T Chu

Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.

Apr 1, 1992·Antimicrobial Agents and Chemotherapy·M J RobinsonN Osheroff

Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays.

Feb 1, 1993·Antimicrobial Agents and Chemotherapy·S W MamberJ Fung-Tomc

Adverse effects of pefloxacin in irradiated C3H/HeN mice: correction with glucan therapy.

Sep 1, 1993·Antimicrobial Agents and Chemotherapy·M L PatchenW E Jackson

Modification of immune response in mice by ciprofloxacin.

Jan 1, 1995·Antimicrobial Agents and Chemotherapy·M Jimenez-ValeraA Ruiz-Bravo

CP-115,953 stimulates cytokine production by lymphocytes.

Feb 1, 1995·Antimicrobial Agents and Chemotherapy·K Riesbeck, A Forsgren

Interaction between DNA gyrase and quinolones: effects of alanine mutations at GyrA subunit residues Ser(83) and Asp(87)

Jun 16, 2001·Antimicrobial Agents and Chemotherapy·F M Barnard, A Maxwell

Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells

Jun 25, 2004·Antimicrobial Agents and Chemotherapy·Silvia M UriarteJames T Summersgill

Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients.

Apr 13, 2012·Journal of Clinical Microbiology·Adalgiza da Silva RochaMaria Leide W de Oliveira

Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay

Jun 15, 2007·Clinical Drug Investigation·Mahmoud Mohamed IssaZainab Assan Kheiralla

Fluoroquinolone adverse effects and drug interactions

Oct 20, 2001·Pharmacotherapy·D N Fish

Inhibitory effects of the quinolone antibiotics trovafloxacin, ciprofloxacin, and levofloxacin on osteoblastic cells in vitro

Dec 16, 2000·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·P D HoltomB Frenkel

4-Quinolones cause a selective loss of mitochondrial DNA from mouse L1210 leukemia cells

Feb 1, 1993·Journal of Cellular Biochemistry·J W LawrenceT C Rowe

The immunomodulatory effects of antibiotics: in vitro and ex vivo investigations of 21 substances by means of the lymphocyte transformation test

Jul 1, 1996·Zentralblatt Für Bakteriologie : International Journal of Medical Microbiology·S SchubertU Ullmann

Synthesis, characterization and antimicrobial investigation of some moxifloxacin metal complexes

Oct 5, 2011·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Sadeek A SadeekMohamed S El-Attar

Synthesis and antibacterial evaluation of novel 8-fluoro Norfloxacin derivatives as potential probes for methicillin and vancomycin-resistant Staphylococcus aureus

Feb 25, 2011·European Journal of Medicinal Chemistry·Naresh SunduruPrem M S Chauhan

Ciprofloxacin-Induced Antibacterial Activity Is Attenuated by Phosphodiesterase Inhibitors

Dec 10, 2015·Current Therapeutic Research, Clinical and Experimental·Majed M MasadehSayer I Al-Azzam

Epigenetic side-effects of common pharmaceuticals: a potential new field in medicine and pharmacology

Jun 9, 2009·Medical Hypotheses·Antonei B Csoka, Moshe Szyf

A rapid in situ procedure for determination of bacterial susceptibility or resistance to antibiotics that inhibit peptidoglycan biosynthesis.

Aug 27, 2011·BMC Microbiology·Rebeca SantisoJosé Luis Fernández

DNA binding, photo-induced DNA cleavage and cytotoxicity studies of lomefloxacin and its transition metal complexes

Dec 30, 2014·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Mohamed A RaghebMervat S Mohamed

Ciprofloxacin-Induced Antibacterial Activity Is Atteneuated by Pretreatment with Antioxidant Agents

Mar 24, 2016·Pathogens·Majed M MasadehAhlam M Al-Buhairan

Embryonic development, locomotor behavior, biochemical, and epigenetic effects of the pharmaceutical drugs paracetamol and ciprofloxacin in larvae and embryos of Danio rerio when exposed to environmental realistic levels of both drugs

Jul 20, 2019·Environmental Toxicology·Ana F NogueiraBruno Nunes

A mutation in yeast topoisomerase II that confers hypersensitivity to multiple classes of topoisomerase II poisons

Mar 14, 2000·The Journal of Biological Chemistry·J DongJ L Nitiss

New 7-piperazinylquinolones containing (benzo[d]imidazol-2-yl)methyl moiety as potent antibacterial agents

Jun 9, 2018·Molecular Diversity·Hojat-Allah ArabSaeed Emami

Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria

Aug 26, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R E Hancock

Emerging Therapeutic Targets Against Toxoplasma gondii: Update on DNA Repair Response Inhibitors and Genotoxic Drugs.

Jul 14, 2020·Frontiers in Cellular and Infection Microbiology·Sergio O AngelWilliam J Sullivan

Synthesis, Molecular Docking and Biological Evaluation of Quinolone Derivatives as Novel Anticancer Agents

Nov 10, 2017·Chemical & Pharmaceutical Bulletin·Jie LiYan-Wen Lv

Vitamin D Pretreatment Attenuates Ciprofloxacin-Induced Antibacterial Activity

Oct 30, 2020·Clinical Pharmacology : Advances and Applications·Majed M MasadehNasr Alrabadi

Effects of low levels of the antibiotic ciprofloxacin on the polychaete Hediste diversicolor: biochemical and behavioural effects.

Oct 2, 2020·Environmental Toxicology and Pharmacology·Ana Filipa Nogueira, Bruno Nunes

Novel 1-8-bridged chiral quinolones with activity against topoisomerase II: stereospecificity of the eukaryotic enzyme.

Apr 1, 1993·Antimicrobial Agents and Chemotherapy·S J Froelich-AmmonN Osheroff

A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential.

Dec 1, 1993·Antimicrobial Agents and Chemotherapy·A H CorbettN Osheroff

Drug features that contribute to the activity of quinolones against mammalian topoisomerase II and cultured cells: correlation between enhancement of enzyme-mediated DNA cleavage in vitro and cytotoxic potential.

Oct 1, 1993·Antimicrobial Agents and Chemotherapy·S H ElseaN Osheroff

Mitochondria and Antibiotics: For Good or for Evil?

Aug 7, 2021·Biomolecules·Juan M Suárez-RiveroJosé A Sánchez-Alcázar

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Related Papers

Effects of ciprofloxacin on the humoral and cellular immune responses in Balb/c-mice

(opens in new tab)
Zentralblatt Für Bakteriologie, Mikrobiologie, Und Hygiene. Series A, Medical Microbiology, Infectious Diseases, Virology, Parasitology
W RoszkowskiG Pulverer
ContactHelpTerms Privacy Cookies
© 2022 Meta ULC. All rights reserved